Sign Up Today and Learn More About Pragma Bio Stock
Invest in or calculate the value of your shares in Pragma Bio or other pre-IPO companies through EquityZen's platform.
Pragma Bio Stock (PRAB)
Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
About Pragma Bio Stock
Founded
2018
Headquarters
Millbrae, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Pragma Bio Press Mentions
Stay in the know about the latest news on Pragma Bio
Pragma Bio Strengthens Strategic Leadership with Addition of Esteemed Advisors and an Independent Board Member
finance • Jun 24, 2024
Pragma Bio on LinkedIn: #diversityinbusiness #innovation #pragmabio
linkedin • May 23, 2024
Pragma Bio Strengthens Strategic Leadership with Addition of Esteemed Advisors and an Independent Board Member
businesswire • May 22, 2024
Systems and methods for identifying microbial biosynthetic genetic clusters
patents • Apr 15, 2024
Pragma Bio and DayTwo Join Forces to Illuminate the Path to IBD Disease Management
businesswire • Apr 06, 2024
Pragma Bio Management
Leadership team at Pragma Bio
Co-Founder & CEO
Kareem Barghouti
Co-Founder
Ayin Vala
Join now and verify your accreditation status to gain access to:
- Pragma Bio current valuation
- Pragma Bio stock price
- Available deals in Pragma Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Pragma Bio stock?
Accredited investors can buy pre-IPO stock in companies like Pragma Bio through EquityZen funds. These investments are made available by existing Pragma Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pragma Bio stock?
Shareholders can sell their Pragma Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
